Report post

What is Seelos Therapeutics?

Seelos Therapeutics is a biopharmaceutical company based in New York City. Founded in 2016, the company is now developing a ketamine spray to treat acute suicidal ideation, Major Depressive Disorder, and Post-Traumatic Stress Disorder. The single-use, bi-dose intranasal spray is currently the company’s only psychedelic-related product.

How have analysts rated Seelos Therapeutics?

Below is a summary of how these 4 analysts rated Seelos Therapeutics over the past 3 months. The greater the number of bullish ratings, the more positive analysts are on the stock and the greater the number of bearish ratings, the more negative analysts are on the stock

Where is Seelos based?

Seelos is based in New York, New York. Seelos’ common stock is traded on The Nasdaq Capital Market under the symbol "SEEL". 14th Fl.

Is Seelos a psychedelic stock?

As of June 2021, Seelos is part of two psychedelic-related stock funds: one listed on a U.S. exchange and the other on a Canadian exchange.

The World's Leading Crypto Trading Platform

Get my welcome gifts